Honest question for the board.. and in asking abou
Post# of 30028
Posted On: 11/19/2014 10:38:14 AM
Honest question for the board.. and in asking about another ticker it is only to get thoughts.
ACTC(now trading as OCAT after recent name change) underwent a 100:1 RS back at end of August 2014 to approx.$8.00/share. They are trading with what I see as mild day-to-day volatility(1 major news trade event in early Sept.) and are down about 20% since the RS…not a huge surprise since they have released very little significant news since the event that would bring them closer to revenues. Their pipeline is weaker, diversity of product is weaker and BOD is weaker than AMBS.
In that same time period, AMBS is trading as volatile as ever and is down closer to 40%. And this is despite putting out some very significant PR’s, adding Rubenfield on the BOD, diversifying their product line, and coming closer to generating revenue of some level in the near future.
So, Option A. –You want less volatility immediately and have no patience for the ongoing growth of this “development” company, then give up 100 of your shares for 1 now and be content.
Option B. Accept that this is a “development” company still “developing” its products. Accept those playing the game will continue to play the game giving us the roller coaster charts we’ve become used to. In the end, you’ll maybe be 20 times, 50 times, or a moon-shot 100 times happier.
This is my take on the situation, but would love to hear other's opinions..
ACTC(now trading as OCAT after recent name change) underwent a 100:1 RS back at end of August 2014 to approx.$8.00/share. They are trading with what I see as mild day-to-day volatility(1 major news trade event in early Sept.) and are down about 20% since the RS…not a huge surprise since they have released very little significant news since the event that would bring them closer to revenues. Their pipeline is weaker, diversity of product is weaker and BOD is weaker than AMBS.
In that same time period, AMBS is trading as volatile as ever and is down closer to 40%. And this is despite putting out some very significant PR’s, adding Rubenfield on the BOD, diversifying their product line, and coming closer to generating revenue of some level in the near future.
So, Option A. –You want less volatility immediately and have no patience for the ongoing growth of this “development” company, then give up 100 of your shares for 1 now and be content.
Option B. Accept that this is a “development” company still “developing” its products. Accept those playing the game will continue to play the game giving us the roller coaster charts we’ve become used to. In the end, you’ll maybe be 20 times, 50 times, or a moon-shot 100 times happier.
This is my take on the situation, but would love to hear other's opinions..
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼